IP Faces Downgraded Targets and Index Risk Ahead of Tuesday Print

International Paper reports third-quarter earnings on October 28 with its shares trading at $33.19, down 7% over the past month and lagging most of its packaging peers, several of which gained 2% to 5% on the week while IP slipped another 2.5%.

The most pointed signal heading into the print is the direction of analyst price targets. Every firm that has moved in the past three weeks has cut. Truist took its target to $41 from $49 on October 12, Wells Fargo moved to $42 from $46 on October 7, UBS slashed to $35 from $47 on October 5, and Citigroup trimmed to $47 from $48 on October 2. All four maintained their existing ratings, which tells a specific story: conviction on the direction of travel is intact, but expectations for the near term have come in sharply. The consensus remains a buy at a mean target of $45.40, implying roughly 37% upside from the current price. That gap between where analysts say the stock should be and where it is trading is the defining tension going into Tuesday.

The short side adds some context but is not the primary story. Short interest is running at 8.4% of the free float, roughly flat over the past week and only modestly higher over the past month. Borrowing is cheap at 0.48% and availability is exceptionally loose, with more than ten shares available to borrow for every one currently lent out. There is no squeeze pressure and no evidence of a sudden build in bearish conviction through the lending market. Options positioning has actually eased from where it was a month ago: the put/call ratio of 1.11 is running slightly below its 20-day average of 1.20, which is a mild contrary signal relative to expectations of defensive loading.

A structural overhang worth noting is ORTEX's Index Rebalance Radar, which puts a 75% probability on IP being deleted from the CRSP US Mid and CRSP US Large indices at the December 2026 quarterly review. The deletion would require index trackers to sell an estimated $225M combined. The rank date is December 4, with the announcement scheduled for December 7 and trades settling on December 22. The price that flips the CRSP rule sits at $39.62, which is 17.6% above current levels. This is not an imminent mechanical event but it introduces a conditional seller into the picture if the stock recovers. A separate ORTEX forecast, carrying 60% probability, points to a share-count reduction in the S&P 500 and Russell indices in connection with an expected EMEA packaging spinoff, with estimated announcement dates around March 2027.

The last two earnings releases both produced negative one-day reactions: a 0.5% drop in May and a 4.2% drop in July, with the five-day follow-through extending the losses further in both cases. The print on Tuesday will test whether the wave of downward target revisions from the past month accurately reflects where the underlying business landed in the third quarter, or whether analysts moved too late and too far in a single direction.